A Feb. 18 decision by the Utah Supreme Court means that more than 1,000 patients are free to pursue claims against Salt Lake City cardiologist Sherman Sorensen, who’s been accused of performing hundreds of unnecessary PFO and ASD closures.

Researchers on the EXCEL trial have been accused of withholding key mortality data when they first published results suggesting stents were as safe as open-heart surgery in treating patients with left main disease.

Philips is launching a new randomized controlled trial—dubbed DEFINE GPS—to assess patient outcomes after PCI guided by instant wave-Free Ratio measurements and angiograms. 

Prolonged cardiac surgery wait times in Wales are forcing physicians to cherry-pick patients for treatment elsewhere, the BBC reported this month.

A review published in Circulation: Cardiovascular Interventions Jan. 24 suggests adjunctive coronary atherectomy is a clinically useful and effective tool for treating severely calcified coronary lesions—but, in reality, it’s rarely used.

In just eight years, the world’s first completely robotic “hybrid” heart will be ready for transplant, according to the Daily Mail.

Repeat revascularization isn’t a rare occurrence after PCI or CABG, according to a study of patients with left main coronary artery disease—but it can raise a person’s risk of cardiovascular death by as much as four times.

Experts at Massachusetts General Hospital have successfully performed five CV transplants using Donation after Circulatory Death donor hearts—the largest number of adult DCD heart transplants ever completed in the U.S.

After a slow start, cardiac ERAS is gaining traction in some U.S. hospitals. Proponents explain how to overcome resistance. 

A study published in JAMA Cardiology Jan. 2 suggests physicians may achieve comparable results when using either radial or femoral access for primary PCI in patients with STEMI.

Hepatitis C-positive donor hearts are a viable long-term option for patients in need of a heart transplant, researchers confirmed in JAMA Cardiology Dec. 18.

Heart transplant patients who live in areas with high levels of air pollution had a 26% higher risk of mortality due to infection in a recent study of nearly 22,000 patients in the U.S.